Post-earnings recap
Reported
Fri, Jan 31, 2014
Est. EPS
—
Est. revenue
—
Implied move
—
EPS beat rate
88%
—
Est. EPS
—
Est. Rev
—
Impl. Move
—
AbbVie's earnings report showed a slight miss on EPS, but the stock reacted positively, rising by 1.9%. Investors may have been encouraged by management's focus on long-term growth and the potential of their product pipeline, despite the lack of revenue data and guidance updates.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.82 | N/A | -1.09% |
Management expressed confidence in their long-term strategy despite the slight EPS miss. They highlighted the potential of their product pipeline.
We remain focused on our long-term growth strategy.
Our pipeline continues to show promise for future developments.